Clinical Trials on Bacterial Transmission in Switzerland

Total 445 results

University Hospital, Basel, Switzerland

Enrolling by invitation

Comparison of Pulsed-field Gel Electrophoresis and Whole Genome Sequencing to Determine Transmission Rate of ESBL-producing E.Coli (PFGE-WGS)

Analysis Transmission Rate

Switzerland
University Hospital, Basel, Switzerland
Stiftung Forschung Infektionskrankheiten, Basel, Switzerland

Completed

Simplified GBS Screening and Prevalence of ESBL in Pregnant Women

Group B Streptococcal Infection | Infection Due to ESBL Bacteria

Switzerland
University of Geneva, Switzerland
Centre Hospitalier Universitaire Vaudois; Cantonal Hospital of St. Gallen

Completed

Antibiotic Durations for Gram-negative Bacteremia (PIRATE)

Bacteraemia Caused by Gram-Negative Bacteria

Switzerland
University of Zurich

Unknown

Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study

Gram-Positive Bacterial Infections

Switzerland
University Hospital Inselspital, Berne

Terminated

Daptomycin in Pediatric Patients With Bacterial Meningitis

Meningitis

Switzerland
University Hospital, Geneva

Completed

Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study

Enterobacteriaceae Infections

Switzerland
University Hospital, Geneva

Unknown

The Burden and Genetic Variability of Extended-Spectrum ß-Lactamase (ESBL) - Producing Pathogens in Swiss Children

Enterobacteriaceae Infections

Switzerland
University Hospital Inselspital, Berne
Tentan AG

Completed

Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis

Bacterial Vaginosis

Switzerland
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults

Tuberculosis (TB)

Switzerland
University Hospital, Basel, Switzerland
Fachhochschule Nordwestschweiz

Withdrawn

miRNA in Sweat, a Novel Digital Biomarker for Detection of Active Tuberculosis (TB)

Active Tuberculosis

Switzerland
University of Zurich

Unknown

Effects of Nutritional Fat on the Growth of Intestinal E. Coli

Escherichia Coli Infections

Switzerland
University Hospital, Basel, Switzerland

Completed

Direct Molecular Characterization of Bacteria From ICU and From the REHAB

Bacterial Infections

Switzerland
GlaxoSmithKline

Completed

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.

Tuberculosis

Switzerland
University Children's Hospital Basel

Terminated

Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis

Streptococcal Infections

Switzerland
University Hospital, Geneva

Completed

An Ecological Analysis of Nontuberculous Mycobacteria in the Geneva Area (2015-2020)

Ecology of Nontubercuous Mycobacteria | Geneva Area

Switzerland
University of Zurich

Recruiting

Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy

Tuberculosis Infection

Switzerland
University Hospital, Basel, Switzerland
propatient foundation Basel

Completed

Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus (TARGET II)

Staphylococcus Aureus Infection

Switzerland
Sanofi

Completed

Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers

Pneumococcal Infections | Pneumococcal Pneumonia

Switzerland
University Hospital, Basel, Switzerland

Completed

Diagnosing of Acute Tuberculosis (SwEaTB)

Tuberculosis

Switzerland
University of Zurich
Ixodes GmbH; Appletree AG

Completed

Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation (IXO-01)

Lyme Disease

Switzerland
University Hospital, Geneva
Ligue Pulmonaire Genevoise

Completed

Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area

Tuberculosis | Latent Tuberculosis Infection

Switzerland
Aeras
Sanofi Pasteur, a Sanofi Company

Completed

A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults (C-013-404)

Tuberculosis

Switzerland
University Hospital, Geneva

Completed

Clinical Metagenomics of Infective Endocarditis (Meta-ENDO)

Infective Endocarditis

Switzerland
University Children's Hospital, Zurich
Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland

Recruiting

Borrelia B-cell Diagnostics (BRILLIANT)

Lyme Disease | Borrelia Infections

Switzerland
University of Bern

Completed

Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea (RaDAR-Go)

Gonorrhoea

Switzerland
University Hospital, Basel, Switzerland
Swiss National Science Foundation

Recruiting

Development of a Swiss Surveillance Database for Molecular Epidemiology of Hypervirulent and Multi-drug Resistant Pathogens

Multiresistant Bacterial Pathogens | Virulent Bacterial Pathogens

Switzerland
University Children's Hospital Basel

Recruiting

BOrrelia BUrgdorferi IN Children and Adolescents (BOBUINCA)

B. Burgdorferi Infection

Switzerland
University Hospital, Geneva
Ligue Pulmonaire Genevoise

Completed

Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis

Tuberculosis

Switzerland
François Spertini
University of Oxford

Completed

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039) (TB039)

Tuberculosis | Mycobacterium Tuberculosis, Protection Against

Switzerland
University Hospital, Geneva
Swiss National Science Foundation; Swiss HIV Cohort Study

Completed

Value of an Intrathecal Synthesis Index of Specific Antitreponema IgG for Neurosyphilis Diagnosis

Neurosyphilis

Switzerland
University Hospital Inselspital, Berne

Recruiting

Cytokine REmoval in CRitically Ill pAtients Requiring Surgical Therapy for Infective Endocarditis (RECReATE) (RECREATE)

Sepsis | Septic Shock | Endocarditis

Switzerland
GlycoVaxyn AG

Completed

Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella

Shigellosis

Switzerland
University Hospital, Basel, Switzerland

Completed

Prosthetic Valve and Graft Endocarditis With Mycobacterium Chimaera

Mycobacterium Chimaera Infections

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Smartphone App-assisted Short-term Antibiotic Therapy (SMAPP)

Infection, Bacterial

Switzerland
University of Zurich

Unknown

Interaction Between Non-typhoid Salmonella, Host Microbiota, and Immune System During Acute Infection and Remission

Salmonella Infection Non-Typhoid

Switzerland
University Hospital, Basel, Switzerland
Gebert Rüf-Stiftung

Active, not recruiting

Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

Extended Spectrum Beta Lactamases (ESBL) E. Coli

Switzerland
University Children's Hospital, Zurich
University Children's Hospital Basel; Ostschweizer Kinderspital

Unknown

Diagnosis of Mycoplasma Pneumoniae Infection With Detection of Specific Antibody-secreting Cells in Community-acquired Pneumonia (CAP) Patients of the Randomised Placebo-controlled Multi-centre Effectiveness Trial of Adjunct Betamethasone Therapy (myKIDS-STEP)

Community-acquired Pneumonia

Switzerland
DBV Technologies
University Hospital, Geneva

Completed

Viaskin Pertussis Vaccine Trial

Whooping Cough

Switzerland
Benoit Guery

Recruiting

Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence (FENDER)

Clostridioides Difficile Infection

Switzerland
Siegrist Claire-Anne
BioNet-Asia Co., Ltd.

Completed

The PertADO Geneva Trial

Pertussis

Switzerland
University of Zurich

Completed

Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.

Community-acquired Pneumonia

Switzerland
University of Zurich

Completed

Effect of Vitamin B12 on the Development of Sepsis, in Culture Positive Patients (Vit B12)

Bacteremia

Switzerland
Juerg Hafner

Recruiting

Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream (LIDOTETRA)

Ulcer, Leg | Ulcus Cruris | Ulcer Venous | Ecthyma

Switzerland
Sanofi

Completed

Study of Two Investigational Pneumococcal Vaccines in Healthy Adults

Pneumococcal Infections | Streptococcus Pneumoniae Infections | Pneumococcal Pneumonia

Switzerland
MerLion Pharmaceuticals GmbH

Terminated

First Time in Man Trial for Friulimicin B

Staphylococcal Skin Infections | Community Acquired Pneumonia

Switzerland
University Hospital Inselspital, Berne

Completed

Epidemiology of Bacteremia at Two Tertiary ICUs in Switzerland

Bacteremia

Switzerland
University of Zurich

Unknown

Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration

Bacteremia

Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults

Pneumococcal Infections | Streptococcus Pneumoniae Infections | Pneumococcal Pneumonia

Switzerland
University Hospital, Geneva
Fonds national Suisse

Completed

Congenital Syphilis in Switzerland

Congenital Syphilis

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection (TARGET III)

Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)

Switzerland

Clinical Trials on Bacterial Transmission in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations